Doing No Harm Starts With Good Hazardous Drug Management
November 25th 2017Oncologists in private offices who supply chemotherapy and biologic infusion therapies for their patients have until recently been exempt from regulations that protect the workplace from aerosolized contaminating agents.
A Payer's Takeaways on the OCM
November 24th 2017In a recent interview with Oncology Business ManagementTM, Peter Aran, MD, medical director of population health management for BlueCross BlueShield of Oklahoma, discussed participation in the Oncology Care Model from CMS, which is designed to improve the quality and value of care.